198 related articles for article (PubMed ID: 19801634)
1. Intracellular autoactivation of human cationic trypsinogen mutants causes reduced trypsinogen secretion and acinar cell death.
Kereszturi E; Sahin-Tóth M
J Biol Chem; 2009 Nov; 284(48):33392-9. PubMed ID: 19801634
[TBL] [Abstract][Full Text] [Related]
2. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.
Geisz A; Hegyi P; Sahin-Tóth M
FEBS J; 2013 Jun; 280(12):2888-99. PubMed ID: 23601753
[TBL] [Abstract][Full Text] [Related]
3. Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.
Joergensen MT; Geisz A; Brusgaard K; Schaffalitzky de Muckadell OB; Hegyi P; Gerdes AM; Sahin-Tóth M
Pancreas; 2011 May; 40(4):540-6. PubMed ID: 21499207
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.
Balázs A; Hegyi P; Sahin-Tóth M
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G477-86. PubMed ID: 26822915
[TBL] [Abstract][Full Text] [Related]
5. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
Szabó A; Sahin-Tóth M
J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
[TBL] [Abstract][Full Text] [Related]
6. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.
Kereszturi E; Szmola R; Kukor Z; Simon P; Weiss FU; Lerch MM; Sahin-Tóth M
Hum Mutat; 2009 Apr; 30(4):575-82. PubMed ID: 19191323
[TBL] [Abstract][Full Text] [Related]
7. Expression of mutated cationic trypsinogen reduces cellular viability in AR4-2J cells.
Gaiser S; Ahler A; Gundling F; Kruse ML; Savkovic V; Selig L; Teich N; Tomasini R; Dagorn JC; Mössner J; Keim V; Bödeker H
Biochem Biophys Res Commun; 2005 Aug; 334(2):721-8. PubMed ID: 16036133
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis.
Schnúr A; Beer S; Witt H; Hegyi P; Sahin-Tóth M
Gut; 2014 Feb; 63(2):337-43. PubMed ID: 23455445
[TBL] [Abstract][Full Text] [Related]
9. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
10. Engineering mouse cationic trypsinogen for rapid and selective activation by cathepsin B.
Demcsák A; Geisz A; Sahin-Tóth M
Sci Rep; 2019 Jun; 9(1):9188. PubMed ID: 31235832
[TBL] [Abstract][Full Text] [Related]
11. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation.
Teich N; Ockenga J; Hoffmeister A; Manns M; Mössner J; Keim V
Gastroenterology; 2000 Aug; 119(2):461-5. PubMed ID: 10930381
[TBL] [Abstract][Full Text] [Related]
12. The guinea pig pancreas secretes a single trypsinogen isoform, which is defective in autoactivation.
Ozsvári B; Hegyi P; Sahin-Tóth M
Pancreas; 2008 Aug; 37(2):182-8. PubMed ID: 18665081
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis.
Szilágyi L; Kénesi E; Katona G; Kaslik G; Juhász G; Gráf L
J Biol Chem; 2001 Jul; 276(27):24574-80. PubMed ID: 11312265
[TBL] [Abstract][Full Text] [Related]
14. Evolution of trypsinogen activation peptides.
Chen JM; Kukor Z; Le Maréchal C; Tóth M; Tsakiris L; Raguénès O; Férec C; Sahin-Tóth M
Mol Biol Evol; 2003 Nov; 20(11):1767-77. PubMed ID: 12832630
[TBL] [Abstract][Full Text] [Related]
15. A preclinical model of chronic pancreatitis driven by trypsinogen autoactivation.
Geisz A; Sahin-Tóth M
Nat Commun; 2018 Nov; 9(1):5033. PubMed ID: 30487519
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cathepsin B does not affect the intracellular activation of trypsinogen by cerulein hyperstimulation in isolated rat pancreatic acinar cells.
Klonowski-Stumpe H; Lüthen R; Han B; Sata N; Häussinger D; Niederau C
Pancreas; 1998 Jan; 16(1):96-101. PubMed ID: 9436869
[TBL] [Abstract][Full Text] [Related]
17. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
Jancsó Z; Sahin-Tóth M
J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary expansion of polyaspartate motif in the activation peptide of mouse cationic trypsinogen limits autoactivation and protects against pancreatitis.
Orekhova A; Németh BC; Jancsó Z; Geisz A; Mosztbacher D; Demcsák A; Sahin-Tóth M
Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G719-G734. PubMed ID: 34643096
[TBL] [Abstract][Full Text] [Related]
19. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.
Kukor Z; Tóth M; Sahin-Tóth M
Eur J Biochem; 2003 May; 270(9):2047-58. PubMed ID: 12709065
[TBL] [Abstract][Full Text] [Related]
20. Mutation That Promotes Activation of Trypsinogen Increases Severity of Secretagogue-Induced Pancreatitis in Mice.
Jancsó Z; Sahin-Tóth M
Gastroenterology; 2020 Mar; 158(4):1083-1094. PubMed ID: 31751559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
